About this Journal Submit a Manuscript Table of Contents
Evidence-Based Complementary and Alternative Medicine
Volume 2012 (2012), Article ID 967968, 9 pages
http://dx.doi.org/10.1155/2012/967968
Research Article

Efficacy of Chuanxiong Ding Tong Herbal Formula Granule in the Treatment and Prophylactic of Migraine Patients: A Randomized, Double-Blind, Multicenter, Placebo-Controlled Trial

1Department of Neurology, Dongzhimen Hospital, Beijing University of Chinese Medicine, No. 5 Haiyun Cang, Dong Cheng District, Beijing 100700, China
2Key Laboratory for Internal Chinese Medicine of Ministry of Education and Beijing, Beijing University of Traditional Chinese Medicine, No. 5 Haiyun Cang, Dong Cheng District, Beijing 100700, China
3Department of Neurology, The Affiliated Hospital to Changchun University of Chinese Medicine, No. 1478 Gongnong Avenue, Chaoyang District, Changchun 130021, China
4Department of Traditional Chinese Medicine, Beijing Tiantan Hospital, Capital Medical University, No. 6 Tiantan Xili, Dong Cheng District, Beijing 100050, China
5Department of Neurology, Taian Hospital of Traditional Chinese Medicine, No. 216 Yingxuan Avenue, Taian 271000, China
6Department of Neurology, Xiamen Hospital of Traditional Chinese Medicine, No. 1739 Xianyue Road, Xiamen 361001, China
7Department of Neurology, Hubei Hospital of Traditional Chinese Medicine, No. 4 Huayuan Shan,Wuchang District, Wuhan 430061, China
8Department of Neurology, The First Subsidiary Affiliated Hospital of Anhui College of Traditional Chinese Medicine, No.117 Meishan Road, Hefei 230031, China
9Department of Neurology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, No. 1 Xiyuan Playground, Haidian District, Beijing 100091, China
10China Academy of Chinese Medical Sciences, No. 16 South Street, Dong zhimen nei, Dong Cheng District, Beijing 100700, China

Received 25 July 2012; Accepted 24 September 2012

Academic Editor: Alan Bensoussan

Copyright © 2012 Caihong Fu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Voigt, J. Liebnitzky, U. Burmeister et al., “Efficacy of osteopathic manipulative treatment of female patients with migraine: results of a randomized controlled trial,” Journal of Alternative and Complementary Medicine, vol. 17, no. 3, pp. 225–230, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. J. J. Gagne, B. Leas, J. H. Lofland, N. Goldfarb, F. Freitag, and S. Silberstein, “Quality of care measures for migraine: a comprehensive review,” Disease Management, vol. 10, no. 3, pp. 138–146, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Diamond, C. Dahlöf, G. Papadopoulos, W. Neto, and S. C. Wu, “Topiramate improves health-related quality of life when used to prevent migraine,” Headache, vol. 45, no. 8, pp. 1023–1030, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. P. J. Goadsby, R. B. Lipton, and M. D. Ferrari, “Migraine—current understanding and treatment,” New England Journal of Medicine, vol. 346, no. 4, pp. 257–270, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. B. Engmann, “Bipolar affective disorder and migraine,” Case Reports in Medicine, vol. 2012, Article ID 389851, 3 pages, 2012. View at Publisher · View at Google Scholar
  6. M. E. Bigal and R. B. Lipton, “The epidemiology, burden, and comorbidities of migraine,” Neurologic Clinics, vol. 27, no. 2, pp. 321–334, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Menken, T. L. Munsat, and J. F. Toole, “The global burden of disease study: Implications for neurology,” Archives of Neurology, vol. 57, no. 3, pp. 418–420, 2000. View at Scopus
  8. Headache Classification Subcommittee of the International Headache Society, “The international classification of headache disorders: 2nd edition,” Cephalalgia, vol. 24, supplement 1, pp. 9–160, 2004.
  9. D. L. Campinha-Bacote, J. B. Kendle, C. Jones et al., “Impact of a migraine management program on improving health outcomes,” Disease Management, vol. 8, no. 6, pp. 382–391, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. P. J. Goadsby and T. Sprenger, “Current practice and future directions in the prevention and acute management of migraine,” The Lancet Neurology, vol. 9, no. 3, pp. 285–298, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. N. M. Ramadan, S. D. Silberstein, F. G. Freitag, et al., “Evidence based guidelines for migraine headache in the primary care setting: pharmacological management for prevention of migraine,” 2007, http://www.aan.com/professionals/practice/pdfs/gl0090.pdf.
  12. S. D. Silberstein, “Preventive treatment of migraine,” Trends in Pharmacological Sciences, vol. 27, no. 8, pp. 410–415, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. R. B. Lipton, W. F. Stewart, R. Cady et al., “Sumatriptan for the range of headaches in migraine sufferers: results of the spectrum study,” Headache, vol. 40, no. 10, pp. 783–791, 2000. View at Publisher · View at Google Scholar · View at Scopus
  14. P. Irimia, J. A. Palma, R. Fernandez-Torron, and E. Martinez-Vila, “Refractory migraine in a headache clinic population,” BMC Neurology, vol. 11, article 94, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. A. I. Scher, W. F. Stewart, and R. B. Lipton, “Caffeine as a risk factor for chronic daily headache: a population-based study,” Neurology, vol. 63, no. 11, pp. 2022–2027, 2004. View at Scopus
  16. P. J. Goadsby, “Is medication-overuse headache a distinct biological entity?” Nature Clinical Practice Neurology, vol. 2, no. 8, p. 401, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. H. S. Boon, D. C. Cherkin, J. Erro et al., “Practice patterns of naturopathic physicians: results from a random survey of licensed practitioners in two US States,” BMC Complementary and Alternative Medicine, vol. 4, article 14, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. L. P. Wang, X. Z. Zhang, J. Guo et al., “Efficacy of acupuncture for migraine prophylaxis: a single-blinded, double-dummy, randomized controlled trial,” Pain, vol. 152, no. 8, pp. 1864–1871, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. L. P. Wang, X. Z. Zhang, J. Guo, et al., “Efficacy of acupuncture for acute migraine attack: a multicenter single blinded, randomized controlled Trial,” Pain Medicine, vol. 13, no. 5, pp. 623–630, 2012. View at Publisher · View at Google Scholar
  20. P. Tfelt-Hansen, G. Block, C. Dahlöf et al., “Guidelines for controlled trials of drugs in migraine: second edition,” Cephalalgia, vol. 20, no. 9, pp. 765–786, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. World Medical Association General Assembly, “World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects,” Journal International de Bioéthique, vol. 15, no. 1, pp. 124–129, 2004.
  22. Y. Nestoriuc, A. Martin, W. Rief, and F. Andrasik, “Biofeedback treatment for headache disorders: a comprehensive efficacy review,” Applied Psychophysiology Biofeedback, vol. 33, no. 3, pp. 125–140, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. C. T. Hartrick, J. P. Kovan, and S. Shapiro, “The numeric rating scale for clinical pain measurement: a ratio measure,” Pain Practice, vol. 3, no. 4, pp. 310–316, 2003. View at Publisher · View at Google Scholar
  24. L. Xiong, Z. Y. Fang, X. N. Tao, M. Bai, and G. Feng, “Effect and mechanism of ligustrazine on Th1/Th2 cytokines in a rat asthma model,” American Journal of Chinese Medicine, vol. 35, no. 6, pp. 1011–1020, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. C. L. Chang, C. S. Lin, and G. H. Lai, “Phytochemical characteristics, free radical scavenging activities, and neuroprotection of five medicinal plant extracts,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 984295, 8 pages, 2012. View at Publisher · View at Google Scholar
  26. J. W. Kim, J. Y. Han, J. T. Hong, et al., “Ethanol extract of the flower Chrysanthemum morifolium augments pentobarbital-induced sleep behaviors: involvement of Cl channel activation,” Evidence-Based Complementary and Alternative Medicine, vol. 2011, Article ID 109164, 7 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. S. J. Day and D. G. Altman, “Blinding in clinical trials and other studies,” British Medical Journal, vol. 321, no. 7259, p. 504, 2000. View at Scopus
  28. S. D. Silberstein and W. Edlund, “Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology,” Neurology, vol. 55, no. 6, pp. 754–762, 2000. View at Scopus